Infections and Infectious Diseases

  • Home
  • Infections and Infectious Diseases
Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing

Condition:   Behavior, Risk
Interventions:   Behavioral: HIV;   Behavioral: General health
Sponsor:   The University of Texas Health Science Center, Houston
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 18, 2019 / by / in
Comparison of Current Standard of Care Versus the Australian Guidelines for Management of Mycoplasma Genitalium Infections Among Men Being Treated for Non-gonococcal Urethritis

Condition:   Mycoplasma Genitalium Infection
Intervention:   Other: Comparison of two stndard of care regimens
Sponsor:   University of Alabama at Birmingham
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 16, 2019 / by / in
Trial to Evaluate the Safety and Intrapulmonary Pharmacokinetics of ZTI-01 (Intravenous Fosfomycin)

Conditions:   Bacterial Infection;   Multiple-drug Resistance;   Pathogen Resistance
Intervention:   Drug: Fosfomycin disodium
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 15, 2019 / by / in
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Conditions:   Acinetobacter Baumannii-calcoaceticus Complex;   Hospital-acquired Bacterial Pneumonia;   Ventilator-associated Bacterial Pneumonia;   Bacteremia;   Colistin Resistant ABC
Interventions:   Drug: ETX2514/Sulbactam + Imipenem/Cilastin;   Drug: Colistin + Imipenem/Cilastin
Sponsor:   Entasis Therapeutics
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 14, 2019 / by / in
Dried Blood Spot Testing of CMV Detection in HCT Recipients

Condition:   Cytomegalovirus Infection
Interventions:   Device: Cytomegalovirus (CMV) polymerase chain reaction (PCR) Dried Blood Spot (DBS) Assay;   Device: DBS Self-Collection Kit;   Other: Standard Control Strategy
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 13, 2019 / by / in
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Conditions:   Acute Leukemia;   Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Acute Lymphoblastic Leukemia;   Mixed Lineage Leukemia;   Lymphoblastic Lymphoma;   Burkitt Lymphoma;   Juvenile Myelomonocytic Leukemia
Intervention:   Device: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
Sponsor:   Children’s Hospital of Philadelphia
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 12, 2019 / by / in
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Condition:   Chronic Granulomatous Disease
Interventions:   Drug: Busulfan;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Sirolimus;   Radiation: Total Body Irradiation;   Biological: Allogeneic peripheral blood stem cell
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 11, 2019 / by / in
An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)

Conditions:   Coccidioidomycosis;   Pneumonia
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 10, 2019 / by / in